View Older Stories View More Recent Stories

Nov 18, 2020 07:13AM Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
Nov 18, 2020 07:00AM Pfizer (PFE), BioNTech (BNTX) Confirm Phase 3 Study of COVID-19 Vaccine Candidate Shows 95% Efficacy
Nov 18, 2020 06:59AM Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
Nov 16, 2020 11:21AM Exclusive: EU eyes COVID vaccine deal with Moderna at less than $25 per dose, says source
Nov 16, 2020 07:31AM Pfizer (PFE) Completes Transaction to Combine Its Upjohn Business with Mylan (MYL)
Nov 16, 2020 07:30AM Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan
Nov 15, 2020 10:10AM Michigan, Washington state impose severe COVID-19 restrictions as U.S. infections soar
Nov 15, 2020 01:08AM Trump briefly admits election defeat, clings to flailing legal strategy
Nov 13, 2020 04:53PM Trump appears to acknowledge for first time that Biden could succeed him
Nov 13, 2020 08:49AM Fed officials differ over economy's risks as coronavirus surges
Nov 12, 2020 12:13PM Pfizer (PFE) Analysis from Phase 3 ATTR-ACT, Extension Study Demonstrates VYNDAQEL 80 mg/VYNDAMAX 61 mg Significantly Improved Survival in Patients with ATTR-CM Compared to VYNDAQEL 20 mg
Nov 12, 2020 12:12PM Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL® 80 mg/VYNDAMAX® 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (A
Nov 11, 2020 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Nov 11, 2020 06:46AM Pfizer (PFE) Reports Positive Results from Fifth Phase 3 Trial of Abrocitinib
Nov 11, 2020 06:45AM Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens
Nov 11, 2020 06:16AM Pfizer (PFE) and BioNTech (BNTX) Confirm Agreement to Supply EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2
Nov 11, 2020 06:15AM Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19
Nov 11, 2020 06:15AM Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2
Nov 9, 2020 11:45AM Transgene Presents E-Poster Outlining Detailed Results from the Phase 1b/2 Trial of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers at SITC 2020
Nov 9, 2020 11:14AM Retail trading hits snags as vaccine news sparks stock scramble
Nov 9, 2020 06:45AM Pfizer (PFE), BioNTech (BNTX) COVID-19 Vaccine Shows Over 90% Efficacy in Phase 3 Study
Nov 9, 2020 06:45AM Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Nov 9, 2020 06:45AM  Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Nov 6, 2020 06:45AM Pfizer (PFE) Announces Positive Phase 3 Study Results for XELJANZ in Ankylosing Spondylitis
Nov 6, 2020 06:45AM Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® (tofacitinib) in Ankylosing Spondylitis (AS)
Nov 5, 2020 08:00AM Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock
Nov 4, 2020 06:17AM Ionis Pharmaceuticals (IONS) Reports Pfizer (PFE) to Begin Phase 2b Clinical Study of Vupanorsen (AKCEA-ANGPTL3-LRx)
Nov 3, 2020 06:00PM Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPTL3-LRx)
Oct 30, 2020 01:39PM Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
Oct 30, 2020 01:24PM Mylan (MYL), Pfizer (PFE) Gain FTC Clearance of Proposed Combination of Mylan and Upjohn
Oct 30, 2020 01:22PM Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
Oct 27, 2020 06:59AM Pfizer (PFE) Announces FDA Grants Priority Review and EMA Accepts Regulatory Submission for Abrocitinib for Patients 12 and Up with Moderate to Severe Atopic Dermatitis
Oct 27, 2020 06:55AM FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis
Oct 27, 2020 02:30AM Transgene Announces Detailed Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-positive Cancers
Oct 21, 2020 08:30AM Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020
Oct 19, 2020 01:30AM Transgene: Acceptance of Late Breaking Abstract at Upcoming SITC 2020 Conference, on The Detailed Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-positive Cancers
Oct 9, 2020 06:46AM GBG and Pfizer (PFE) Announce PENELOPE-B Trial of IBRANCE in Early Breast Cancer Did Not Meet Primary Endpoint
Oct 9, 2020 06:45AM PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint
Oct 8, 2020 06:49AM Pfizer (PFE) Phase 3 Once-Weekly Investigational Study of Somatrogon to Treat Children with GHD Met its Primary Endpoint
Oct 8, 2020 06:45AM Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
Oct 7, 2020 06:48AM Pfizer (PFE), Sangamo Therapeutics Inc. (SGMO) Report First Participant Dosing in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment
Oct 7, 2020 06:45AM Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment
Oct 7, 2020 06:24AM Exact Sciences (EXAS), Pfizer (PFE) Extend and Amend Cologuard Promotion Agreement
Oct 7, 2020 06:11AM Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement
Oct 6, 2020 12:56PM U.S. FDA safety guidelines likely to push COVID-19 vaccine authorization past election
Oct 6, 2020 06:06AM BioNTech (BNTX) and Pfizer (PFE) Initiate Rolling Submission to EMA for SARS-CoV-2 Vaccine Candidate BNT162b2
Oct 6, 2020 05:01AM BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
Oct 5, 2020 06:33AM SpringWorks Therapeutics Inc. (SWTX), Pfizer Inc. (PFE) Report Clinical Collaboration to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myelom
Oct 5, 2020 06:30AM SpringWorks Therapeutics Announces Clinical Collaboration with Pfizer Inc. to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myeloma
Oct 5, 2020 06:30AM SpringWorks Therapeutics Announces Clinical Collaboration with Pfizer Inc. to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myeloma
View More Recent Stories View Older Stories